2026 ICD-10-CM Diagnosis Code C47.4Malignant neoplasm of peripheral nerves of abdomen

ICD-10-CM CodesC00–D49C45-C49C47

ICD-10-CM C47.4
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C47.4 is a billable ICD-10-CM diagnosis code for malignant neoplasm of peripheral nerves of abdomen. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 542 through 544. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 2 closely related codes. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Nervous system cancers - all other types.

For Medicare Advantage risk adjustment, C47.4 maps to CMS-HCC Category 23 (Prostate, Breast, and Other Cancers and Tumors) under the V28 model, adding a risk factor of about 0.186 for a community, non-dual, aged beneficiary in payment year 2026.

Code Identity

ICD-10-CM Code
C47.4
Billable Status
Yes — Valid for Submission
Code Describes
Malignant neoplasm of peripheral nerves of abdomen
Short Description
Malignant neoplasm of peripheral nerves of abdomen
Same as the full description in the CMS dataset.
Parent Code
Malignant neoplasm of peripheral nerves and autonomic nervous system

Code Classification

ChapterC00–D49Neoplasms
SectionC45-C49Malignant neoplasms of mesothelial and soft tissue
CategoryC47Malignant neoplasm of peripheral nerves and autonomic nervous system
This CodeC47.4Malignant neoplasm of peripheral nerves of abdomen

Medicare Risk Adjustment (HCC)Billing

C47.4 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.

CMS-HCC V28 Category (Payment Model)
HCC 23— Prostate, Breast, and Other Cancers and Tumors
Payment HCC · PY 2026 one of 234 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.186
community, non-dual, aged · ranges 0.186–0.237 across segments
Hierarchy
Superseded by HCC 17, HCC 18, HCC 19, HCC 20, HCC 21, and HCC 22
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 10
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 10 · ESRD (V21): HCC 10 · ESRD (V24): HCC 10
ESRD V21 weights: 0.136 dialysis, 0.451–0.668 functioning graft · ESRD V24 weights: 0.111 dialysis, 0.467–0.780 functioning graft
Part D (RxHCC)
RxHCC 20 — Lung, Kidney, and Other Cancers; Secondary Cancer of Lymph Nodes and Other Sites
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Malignant neoplasm of peripheral nerve of abdomen
  • Malignant nerve sheath neoplasm of peripheral nerve of abdomen
  • Neoplasm of peripheral nerves of abdomen
  • Primary malignant neoplasm of peripheral nerves of abdomen
  • Primary malignant neoplasm of peripheral nerves of trunk
  • Primary malignant nerve sheath neoplasm of peripheral nerve of abdomen
  • Primary malignant nerve sheath neoplasm of peripheral nervous system structure

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO049
Nervous system cancers - all other types
Default principal diagnosis: inpatient Yes · outpatient Yes

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
nerve (ganglion) peripheral NEC abdomenC47.4C79.89D36.15D48.2D49.2
nerve (ganglion) peripheral NEC abdominal wallC47.4C79.89D36.15D48.2D49.2
nerve (ganglion) peripheral NEC umbilicusC47.4C79.89D36.15D48.2D49.2

Patient EducationClinical

Cancer

Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.

The full article covers:

  • What is cancer?
  • What are the types of cancer?
  • How does cancer develop?
  • What are the symptoms of cancer?
  • How is cancer diagnosed?
  • What are the treatments for cancer?
  • Can cancer be prevented?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C47.4 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
171.5 Mal neo soft tis abdomen
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C47.4Overview

What is the ICD-10 code for malignant neoplasm of peripheral nerves of abdomen?

The ICD-10-CM code for malignant neoplasm of peripheral nerves of abdomen is C47.4 (sometimes written as C474). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is C47.4 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of peripheral nerves of abdomen on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C47.4 group to?

When malignant neoplasm of peripheral nerves of abdomen is the principal diagnosis on an inpatient stay, it groups to MS-DRG 542, 543, 544, with relative weights from 0.7546 to 1.7665 depending on complications. Higher weights mean higher Medicare reimbursement.

Is C47.4 a CC or MCC?

CMS lists C47.4 as a CC (complication or comorbidity) for FY 2026. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 2 closely related codes in its exclusion list.

What is the ICD-9 equivalent of C47.4?

Under the General Equivalence Mappings, malignant neoplasm of peripheral nerves of abdomen converts to ICD-9-CM 171.5 (mal neo soft tis abdomen). The mapping is approximate, so confirm the match fits the documentation.

What HCC is C47.4?

C47.4 (malignant neoplasm of peripheral nerves of abdomen) maps to CMS-HCC Category 23 (Prostate, Breast, and Other Cancers and Tumors), commonly written as HCC 23, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 10 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 20.

Does C47.4 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, C47.4 adds a risk adjustment factor of about 0.186 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.186 to 0.237 depending on the payment segment). A more severe related category (HCC 17, HCC 18, HCC 19, HCC 20, HCC 21, and HCC 22) supersedes it when both are reported. See the full factor table on the HCC 23 category page.